Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 236-068-5 | CAS number: 13138-45-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu./o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
Value used for CSA (read-across from Nickel sulphate or Nickel ion):
NOAEL (oral, systemic, animal): 100 mg NiSO4.6H2O/kg bw(22 mg Ni/kg bw/day) (FDRL, 1983)
LOAEL (oral, systemic, human data): 0.012 mg Ni (Ni ion)/kg bw/day released from metallic nickel in water and food contact material (Nielsen et al 1999)
NOAEC (inhalation, systemic, animal): 0.53 mg NiSO4.6H2O/L air (120 mg Ni/m3) (EPSL, 2009a)
LOAEC (inhalation, local, animal data): 0.7 mg Ni/m3(DNEL calculation is based on 16-day repeated dose study-Benson et al, 1988; no acute data was available)
An acute local inhalation DNEL is derived based on the lung effects (e.g. lung inflammation) associated with nickel sulphate inhalation. The shortest-term study available examining those effects in animals is a 16-day repeated exposure study. An adjustment factor was derived to extrapolate the results from the repeated exposure study to an equivalent effect concentration in a 4 hr acute exposure. See Appendix C3 for more information.
(Oral, local values are not applicable; Dermal, local or systemic, values are not applicable)
Key value for chemical safety assessment
Additional information
There is data from one acute LD50 oral rat study (Smyth et al, 1969) and three acute oral toxic class method studies (Phycher, 2003a, b, c) on nickel nitrate. The Smyth et al. (1969) study gave an LD50 value of 1620 mg Ni-nitrate/kg. The study method deviates from the Annex V method in several important respects. Only one sex was used (males), and the animals were not fasted prior to dosing. Lower LD50 values were reported for females than for males for another nickel soluble compound, nickel sulphate (FDRL 1983). Therefore, it is possible that a lower LD50 value would have been determined for nickel nitrate if the female sex had been included in the Smyth et al. study. Furthermore, the uptake following oral exposure is known to depend greatly on the presence of food in the gastrointestinal tract. The uptake in fasting individuals is approximately 30%, while in non-fasting individuals a much smaller fraction is absorbed, estimated as 5% (see section on toxicokinetics for further details). The Smyth et al. study, using non-fasted rats, was thus likely to yield a higher LD50 value than a study using fasted rats. In conclusion, the Smyth et al. study is expected to underestimate the toxicity compared to an Annex V test. The results of the three formulations tested by the acute toxic class method show a result in the range between 200 and 2000 mg/kg. However, an LD50 could not be determined with only two doses (including the limit dose).
A GLP, OECD-guideline compliant acute oral toxicity study (EPSL, 2009b) and an FDRL (1983) study will be read-across from nickel sulphate. Effects data from these studies will be read-across to Ni nitrate to complete the DNEL derivation: LD50 of 361.9 mg NiSO4/kg/bw (EPSL, 2009a) and NOAEL of 100 mg NiSO4.6H2O/kg (or 22 mg Ni/kg) (FDRL, 1983). A comprehensive read-across assessment was recently completed based on bioaccessibility data in synthetic gastric fluid of various nickel compounds combined in vivo verification data for three source nickel substances. The read-across paradigm presented in a summary document in IUCLID Section 7.2.1 and Appendix B1 of the CSR enables grouping of target Ni substances for classification purposes according to bioaccessibility in gastric fluid. This assessment supports that nickel nitrate should be read-across from Ni sulphate for acute oral toxicity.
Data regarding the potential acute inhalation toxicity of Ni nitrate are read-across from Ni sulphate. A comprehensive read-across assessment was recently completed based on bioaccessibility data in synthetic lung fluids of various nickel compounds combined in vivo verification data for three source nickel substances. The read-across paradigm presented in a summary document in Section 7.2.2 and in Appendix B2 to the CSR enables grouping of target Ni substances for classification purposes according to bioaccessibility in interstitial fluid as demonstrated. The outcome of this assessment indicates that soluble nickel compounds, such as nickel nitrate, should be read-across from Ni sulphate, which has been shown to have an acute inhalation LC50 of 2.48 mg NiSO4/L and a NOAEC of 0.53 mg NiSO4.6H2O/L air (120 mg Ni/m3) (EPSL, 2009). Therefore, application of this read-across paradigm supports the current harmonized classification of Acute Tox 4; H332 for Ni nitrate.
There are no available data on which to evaluate acute dermal toxicity. However, acute toxicity is expected to be low in view of the poor absorption by this route. As oral and inhalation routes of exposure are more relevant and data for these have been provided, testing for acute dermal toxicity is therefore waived based on this information.
The following information is taken into account for any hazard / risk assessment:
ORAL: No reliable standard acute oral toxicity tests are available for nickel dinitrate. Data for acute oral toxicity of Ni nitrate will be read-across from Ni sulphate to fulfill the testing requirement and use in DNEL derivation: LD50 of 361.9 mg NiSO4/kg/bw and NOAEL of 100 mg NiSO4.6H2O/kg (or 22 mg Ni/kg).
INHALATION: Animal studies of toxicity via inhalation are lacking, and no human data on the toxicity of nickel nitrate via this route have been found. Data will be read-across from Ni sulphate for acute inhalation toxicity: LC50 of 2.48 mg NiSO4/L and a NOAEC of 0.53 mg NiSO4.6H2O/L air (120 mg Ni/m3).
DERMAL: No risk characterisation will be conducted for acute dermal toxicity. Acute systemic effects are not relevant due to the very low dermal absorption of nickel. Acute local effects are covered by the long term DNEL based on prevention of dermal sensitization.
Justification for classification or non-classification
Ni nitrate is classified as Acute Tox. 4; H302 and Acute Tox.4:H332 in the 1st ATP to the CLP Regulation. Background information supporting this classification has been provided in the section above.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)